Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection

BX795 Demonstrates Potent Antiviral Benefits against Herpes Simplex Virus-1 Infection of Human Cell Lines

(2020) Aqsa Iqbal et al.   ANTIVIRAL RESEARCH

In Vitro and In Vivo Activity, Tolerability and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus-2 Genital Infection

(2020) James Hopkins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing

(2020) Tejabhiram Yadavalli et al.   Science Advances

Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery

(2019) Tejabhiram Yadavalli et al.   Science Advances

An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye

(2018) Dinesh Jaishankar et al.   Science Translational Medicine

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

(2018) Randy A. Taplitz et al.   JOURNAL OF CLINICAL ONCOLOGY

PubChem 2019 update: improved access to chemical data

(2018) Sunghwan Kim et al.   NUCLEIC ACIDS RESEARCH

Antiviral drug resistance in herpesviruses other than cytomegalovirus

(2014) Jocelyne Piret et al.   REVIEWS IN MEDICAL VIROLOGY

Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management

(2010) Jocelyne Piret et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

(2009) Garrett M. Morris et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY

Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis

(2008) D Goldblum et al.   BRITISH JOURNAL OF OPHTHALMOLOGY